| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.24 | 4e-05 |